Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Capital Employed: 2022-2024

Historic Return on Capital Employed for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Dec 2024 value amounting to -0.10%.

  • Kiniksa Pharmaceuticals International's Return on Capital Employed rose 13.00% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 13.00%. This contributed to the annual value of -0.10% for FY2024, which is 4.00% down from last year.
  • According to the latest figures from FY2024, Kiniksa Pharmaceuticals International's Return on Capital Employed is -0.10%, which was down 71.65% from -0.06% recorded in FY2023.
  • Kiniksa Pharmaceuticals International's Return on Capital Employed's 5-year high stood at 0.03% during FY2022, with a 5-year trough of -0.10% in FY2024.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Return on Capital Employed value was -0.06% (recorded in 2023), while the average stood at -0.04%.
  • Data for Kiniksa Pharmaceuticals International's Return on Capital Employed shows a maximum YoY decreased of 9bps (in 2023) over the last 5 years.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's Return on Capital Employed (Yearly) stood at 0.03% in 2022, then dropped by 9bps to -0.06% in 2023, then decreased by 4bps to -0.10% in 2024.